Lemke H - Search Results

1

Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitis.

Fölster-Holst R, Henseler T, Wehde J, Lemke H, Weichenthal M, Christophers E, Hansen HP. Fölster-Holst R, et al. Among authors: lemke h. Acta Derm Venereol. 2002;82(4):245-8. doi: 10.1080/000155502320323180. Acta Derm Venereol. 2002. PMID: 12361126 Free article.

2

High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis.

Wang G, Hansen H, Tatsis E, Csernok E, Lemke H, Gross WL. Wang G, et al. Among authors: lemke h. Am J Med. 1997 Jun;102(6):517-23. doi: 10.1016/s0002-9343(97)00049-1. Am J Med. 1997. PMID: 9217665

3

Inhibition of metalloproteinases enhances the internalization of anti-CD30 antibody Ki-3 and the cytotoxic activity of Ki-3 immunotoxin.

Hansen HP, Matthey B, Barth S, Kisseleva T, Mokros T, Davies SJ, Beckett RP, Foelster-Holst R, Lange HH, Engert A, Lemke H. Hansen HP, et al. Among authors: lemke h. Int J Cancer. 2002 Mar 10;98(2):210-5. doi: 10.1002/ijc.10182. Int J Cancer. 2002. PMID: 11857410

4

A zinc metalloproteinase is responsible for the release of CD30 on human tumor cell lines.

Hansen HP, Kisseleva T, Kobarg J, Horn-Lohrens O, Havsteen B, Lemke H. Hansen HP, et al. Among authors: lemke h. Int J Cancer. 1995 Nov 27;63(5):750-6. doi: 10.1002/ijc.2910630524. Int J Cancer. 1995. PMID: 7591296

5

Non-genetic inheritable potential of maternal antibodies.

Lemke H, Hansen H, Lange H. Lemke H, et al. Vaccine. 2003 Jul 28;21(24):3428-31. doi: 10.1016/s0264-410x(03)00394-3. Vaccine. 2003. PMID: 12850353

6

The ectodomain shedding of CD30 is specifically regulated by peptide motifs in its cysteine-rich domains 2 and 5.

Hansen HP, Recke A, Reineke U, Von Tresckow B, Borchmann P, Von Strandmann EP, Lange H, Lemke H, Engert A. Hansen HP, et al. Among authors: lemke h. FASEB J. 2004 May;18(7):893-5. doi: 10.1096/fj.03-0901fje. Epub 2004 Mar 19. FASEB J. 2004. PMID: 15033921

7

Protein kinase activity of the intracellular but not of the membrane-associated form of the Ki-1 antigen (CD30).

Hansen H, Bredfeldt G, Havsteen B, Lemke H. Hansen H, et al. Among authors: lemke h. Res Immunol. 1990 Jan;141(1):13-31. doi: 10.1016/0923-2494(90)90098-j. Res Immunol. 1990. PMID: 2161115

8

Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4).

Horn-Lohrens O, Tiemann M, Lange H, Kobarg J, Hafner M, Hansen H, Sterry W, Parwaresch RM, Lemke H. Horn-Lohrens O, et al. Among authors: lemke h. Int J Cancer. 1995 Feb 8;60(4):539-44. doi: 10.1002/ijc.2910600419. Int J Cancer. 1995. PMID: 7530238

9

CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme.

Hansen HP, Dietrich S, Kisseleva T, Mokros T, Mentlein R, Lange HH, Murphy G, Lemke H. Hansen HP, et al. Among authors: lemke h. J Immunol. 2000 Dec 15;165(12):6703-9. doi: 10.4049/jimmunol.165.12.6703. J Immunol. 2000. PMID: 11120787

10

Vitronectin- and fibronectin-containing immune complexes in primary systemic vasculitis.

Maehnss K, Kobarg J, Schmitt WH, Hansen HP, Lange H, Csernok E, Gross WL, Lemke H. Maehnss K, et al. Among authors: lemke h. J Autoimmun. 2002 May;18(3):239-50. doi: 10.1006/jaut.2002.0582. J Autoimmun. 2002. PMID: 12126637

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters